• Vitamin supplementation in patients whose requirements for vitamins contained in this product are increasing and who cannot take adequate vitamins through oral intake of foods (e.g., wasting disease, women during pregnancy or lactation)
• In any of the following conditions in which deficiencies or metabolic disorders of vitamins contained in this product are estimated to be involved:

           Neuralgia, myalgia/arthralgia, peripheral neuritis/nerve palsy

         For patients showing no response, Shigmabitan should not be administered unthoughtfully over a number of months.

• Benfotiamine - 34.58 mg

          (as Thiamine Chloride Hydrochloride 25 mg)

• Pyridoxine Hydrochloride (JP) - 25 mg
• Cyanocobalamin (JP) - 0.25 mg